Deleterious Effect of Glucose Pretreatment on Recovery from Diffuse Cerebral Ischemia in the Cat. I. Local Cerebral Blood Flow and Glucose Utilization
Overview
Neurology
Authors
Affiliations
Diffuse cerebral ischemia was created in pentobarbital-anesthetized cats by basilar and bilateral carotid artery occlusions and hypotension. Local cerebral blood flow (ICBF) was assessed autoradiographically with 14C-antipyrine, and local cerebral glucose utilization with 14C-2-deoxyglucose. In animals without glucose pretreatment, 15 min of ischemia led to a homogeneous reduction of post-ischemic cerebral perfusion to 31% of control; ischemia of 30 min produced post-ischemic perfusion heterogeneities in the cerebral cortex and deep gray structures. In animals pretreated with dextrose, 1.5 gm/kg intravenously, heterogeneous cerebral perfusion was observed following only 15 min of ischemia, and a severe global impairment of cerebral reperfusion occurred after the 30 min insult. Deoxyglucose autoradiograms in the latter animals were remarkable for a complete suppression of tracer uptake in the cerebral cortex and a paradoxically increased tracer concentration in the cerebral white matter. Mean plasma glucose in the treated animals exceeded 1000 mg/100 ml. Large glucose loads prior to ischemia dramatically impair post-ischemic cerebral perfusion.
Yao M, Hao Y, Wang T, Xie M, Li H, Feng J Front Neurol. 2023; 14:1149671.
PMID: 37025208 PMC: 10070880. DOI: 10.3389/fneur.2023.1149671.
Wang E, Lai T eNeuro. 2021; 8(6).
PMID: 34862204 PMC: 8721515. DOI: 10.1523/ENEURO.0346-21.2021.
Laredo C, Renu A, Llull L, Tudela R, Lopez-Rueda A, Urra X Sci Rep. 2020; 10(1):10588.
PMID: 32601437 PMC: 7324383. DOI: 10.1038/s41598-020-67448-x.
Reiche E, Gelinksi J, Alfieri D, Flauzino T, Lehmann M, de Araujo M Metab Brain Dis. 2019; 34(3):789-804.
PMID: 30875023 DOI: 10.1007/s11011-019-00403-6.
Diabetic aggravation of stroke and animal models.
Rehni A, Liu A, Perez-Pinzon M, Dave K Exp Neurol. 2017; 292:63-79.
PMID: 28274862 PMC: 5400679. DOI: 10.1016/j.expneurol.2017.03.004.